Patents by Inventor Nigel D. A. Walshe

Nigel D. A. Walshe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7494992
    Abstract: The present invention relates to novel terpene alkaloids and their use as antiparasitic agents. The present invention also relates to an antiparasitic agent which comprises a terpene alkaloid compound of this invention as an effective ingredient in an antiparasitic formulation. More particularly, the present invention relates to derivatives of the terpene alkaloid (1S,2R,4aS,5R,8R,8aR)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(1-methylethenyl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl (2S,3aR,9bR)-6-chloro-9b-hydroxy-5-methyl-1,2,3,3a,5,9b-hexahydropyrrolo[2,3-c][2,1]benzoxazine-2-carboxylate. Pharmaceutical compositions comprising the same are also disclosed.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: February 24, 2009
    Assignee: Pfizer Inc.
    Inventors: Nathan A. Chubb, Douglas J. Critcher, James J. Eshelby, Graham Lunn, Andrew J. Rudge, Nigel D. Walshe, Paul H Wiedenau, David H. Williams
  • Patent number: 6906184
    Abstract: An improved process for the preparation of the antiparasitic compound 25-cyclohexyl-22,23-dihydro-5-hydroxyiminoavermectin B1 monosaccharide from doramectine and intermediates therefor and crystalline solvates thereof.
    Type: Grant
    Filed: July 23, 1998
    Date of Patent: June 14, 2005
    Assignee: Pifzer, Inc.
    Inventors: Nigel D. Walshe, Selena J. Cambers
  • Patent number: 5112746
    Abstract: Antiparasitic compounds of formula (I): ##STR1## The broken line at the 22-23 position representing an optional double bond and either R.sup.1 is H or OH and the double bond is absent or the double bond is present and R.sup.1 is absent; R.sup.2 is optionally substituted phenyl, or a group of formula (II): ##STR2## wherein X is O, S or --CH.sub.2 --, abc and d are 0-2 and a+b+c+d.ltoreq.5 R.sup.3 is H or MeR.sup.4 is H, OH or 4'-(alpha-L-oleandrosyl)-alpha-L-oleandrosyloxy.The compounds are prepared by fermentation of Streptomyces avermitilis in the presence of an N-alkanoyl cysteamine thioester containing R.sup.2.
    Type: Grant
    Filed: June 21, 1991
    Date of Patent: May 12, 1992
    Assignee: Pfizer Inc.
    Inventors: Christopher J. Dutton, Stephen P. Gibson, Nigel D. A. Walshe
  • Patent number: 5095127
    Abstract: A new acidic polycyclic antibiotic UK-61,689 has the formula: ##STR1## or a pharmaceutically acceptable cationic salt thereof. The antibiotic and its cationic salts are active against a variety of microorganisms and are effective in controlling coccidiosis, enteritis and swine dysentery as well as being effective in promotion of growth and/or improving efficiency of feed utilization in swine and ruminants.
    Type: Grant
    Filed: December 17, 1990
    Date of Patent: March 10, 1992
    Assignee: Pfizer Inc.
    Inventors: Alexander C. Goudie, Nigel D. A. Walshe
  • Patent number: 5057498
    Abstract: Antiparasitic compounds of formula (I): ##STR1## The broken line at the 22-23 position representing an optional double bond and either R.sup.1 is H or OH and the double bond is absent or the double bond is present and R.sup.1 is absent; R.sup.2 is optionally substituted phenyl, or a group of formula (II): ##STR2## wherein X is O, S or --CH.sub.2 13 , abc and d are 0-2 and a+b+c+d.ltoreq.5R.sup.3 is H or MeR.sup.4 is H, OH or 4'-(alpha-L-oleandrosyl)-alpha-L-oleandrosyloxy.The compounds are prepared by fermentation of Streptomyces avermitilis in the presence of an N-alkanoyl cysteamine thioester containing R.sup.2.
    Type: Grant
    Filed: August 29, 1990
    Date of Patent: October 15, 1991
    Assignee: Pfizer Inc.
    Inventors: Christopher J. Dutton, Stephen P. Gibson, Nigel D. A. Walshe
  • Patent number: 4992466
    Abstract: A new acidic polycyclic antibiotic UK-61,689 has the formula: ##STR1## or a pharmaceutically acceptable cationic salt thereof. The antibiotic and its cationic salts are active against a variety of microorganisms and are effective in controlling coccidiosis, enteritis and swine dysentery as well as being effective in promotion of growth and/or improving efficiency of feed utilization in swine and ruminants.
    Type: Grant
    Filed: February 20, 1990
    Date of Patent: February 12, 1991
    Assignee: Pfizer Inc.
    Inventors: Alexander C. Goudie, Nigel D. A. Walshe
  • Patent number: 4980370
    Abstract: Antiparasitic compound of formula (I): ##STR1## The broken line at the 22-23 position representing an optional double bond and eitherR.sup.1 is a H or OH and the double bond is absent or the double bond is present and R.sup.1 is absent;R.sup.2 is optionally substituted phenyl, or a group of formula (II): ##STR2## wherein X is O, S or --CH.sub.2 --, abc and d are 0-2 and a+b+c+d.ltoreq.5 R.sup.3 is H or MeR.sup.4 is H, OH or 4'-(alpha-L-oleandrosyl)-alpha-L-oleandrosyloxy.The compounds are prepared by fermentation of Streptomyces avermitilis in the presence of an N-alkanoyl cysteamine thioester containing R.sup.2.
    Type: Grant
    Filed: June 26, 1989
    Date of Patent: December 25, 1990
    Assignee: Pfizer Inc.
    Inventors: Christopher J. Dutton, Stephen P. Gibson, Nigel D. A. Walshe
  • Patent number: 4912130
    Abstract: A new acidic polycyclic antibiotic UK-61,689 has the formula: ##STR1## or a pharmaceutically acceptable cationic salt thereof. The antiobiotic and its cationic salts are active against a variety of microorganisms and are effective in controlling coccidiosis, enteritis and swine dysentery as well as being effective in promotion of growth and/or improving efficiency of feed utilization in swine and ruminants.
    Type: Grant
    Filed: December 6, 1988
    Date of Patent: March 27, 1990
    Assignee: Pfizer Inc.
    Inventors: Alexander C. Goudie, Nigel D. A. Walshe
  • Patent number: 4804680
    Abstract: A new acidic polycyclic antibiotic UK-61,689 has the formula: ##STR1## or a pharmaceutically acceptable cationic salt thereof. The antibiotic and its cationic salts are active against a variety of microorganisms and are effective in controlling coccidiosis, enteritis and swine dysentery as well as being effective in promotion of growth and/or improving efficiency of feed utilization in swine and ruminants.
    Type: Grant
    Filed: July 21, 1987
    Date of Patent: February 14, 1989
    Assignee: Pfizer Inc.
    Inventors: Alexander C. Goudie, Nigel D. A. Walshe